The treatment pipeline for generalized myasthenia gravis (gMG) continues to be active, a consequence of the ongoing progress in knowledge that led to approval of six new drugs for the disease. In ...

GMG has received formal requests to distribute G® Lubricant in a number of additional countries and is working through the process to commence these distribution deals, including packaging and ...

Heightened focus on delays in diagnosing generalized myasthenia gravis (gMG) follows the promise of better results for some patients with newer treatments that include complement inhibitors and ...

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved patient outcomes across diverse populations.

Goodman Group (GMG), an ASX-listed company, is a Company engaged in investment in industrial property (either directly or in partnerships with other investors) and management services provided to the ...

GMG:CA Company Profile Graphene Manufacturing Group Ltd, a clean-technology, provides energy saving and energy storage solutions enabled by graphene in Australia.

Rystiggo is one of a pair of new therapies developed by UCB as it tries to grab a slice of the gMG market, along with zilucoplan, a once-daily C5 inhibitor given by subcutaneous injection that is ...

J&J files FcRn blocker nipocalimab for generalised myasthenia gravis (gMG) in US, setting up a challenge to rival drugs from Argenx and UCB ...

Get the latest Graphene Manufacturing Group Ltd (GMG.V) stock news and headlines to help you in your trading and investing decisions.

Graphene Manufacturing Group Ltd is involved in the production of high-quality graphene used predominantly in paints, coolants, and lubricants targeting to improve energy efficiency and reduce costs, ...